MedTrace Logo

Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

NCT03933605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2019-05-01

No results posted yet for this study

Summary

In the present study, midazolam and palonosetron in combination were more effective than palonosetron alone in lowering the incidence and severity of postoperative nausea and vomiting in the initial 2 h after laparoscopic cholecystectomy. Postoperative clinical complications were not different in both groups.

Conditions

  • Postoperative Nausea
  • Postoperative Vomiting

Interventions

DRUG

midazolam and palonosetron group

intravenous midazolam and palonosetron administraion as prevention of postoperative nausea and vomiting

DRUG

palonosetron group

intravenous palonosetron administraion as prevention of postoperative nausea and vomiting

Sponsors & Collaborators

  • Yeungnam University College of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-10
Primary Completion
2019-02-01
Completion
2019-02-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933605 on ClinicalTrials.gov